This chapter describes individual interventions for HIV prevention from the perspective of a three-stage model of behavioral therapy development. This is highly applicable to individual interventions for HIV prevention, due to the sequential approach to designing and refining culturally appropriate interventions. The chapter reviews the most common theoretical models used to design behavioral interventions, and how successful they have been when applied to individual interventions for HIV risk behaviors. In biomedical intervention development, clinical researchers use the regulatory standards set forth by the Food and Drug Administration (FDA) for pharmacotherapy and other biomedical clinical intervention trials. The AIDS risk reduction model (ARRM) is one of several stages of change models that posit behavior change to be a process in which individuals move from one step to the next as a result of a given stimulus. The ARRM combines aspects of the health belief model, the diffusion of innovation theory, and social cognitive theory. In the ARRM, an individual must pass through three stages: behavior labeling, commitment to change, and taking action. Consequently, interventions using this model focus on conducting an individual risk assessment, influencing the decision to reduce risk through perceptions of enjoyment or self-efficacy, and assisting the individual with support to enact the change.
|Original language||English (US)|
|Title of host publication||HIV Prevention|
|Number of pages||37|
|State||Published - Dec 1 2009|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)